ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 147 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $402,924 | -23.6% | 134,308 | -4.8% | 0.00% | -100.0% |
| Q2 2023 | $527,545 | +127326.3% | 141,055 | +14.0% | 0.00% | 0.0% |
| Q1 2023 | $414 | -27.1% | 123,687 | +4.7% | 0.00% | 0.0% |
| Q4 2022 | $568 | -99.9% | 118,093 | +1.7% | 0.00% | 0.0% |
| Q3 2022 | $661,000 | -15.1% | 116,114 | +5.8% | 0.00% | 0.0% |
| Q2 2022 | $779,000 | +31.1% | 109,712 | +33.4% | 0.00% | 0.0% |
| Q1 2022 | $594,000 | -23.0% | 82,237 | -4.6% | 0.00% | 0.0% |
| Q4 2021 | $771,000 | -74.3% | 86,239 | +0.6% | 0.00% | -75.0% |
| Q3 2021 | $3,004,000 | +70.4% | 85,692 | +4.4% | 0.00% | +100.0% |
| Q2 2021 | $1,763,000 | +66.3% | 82,096 | +378.3% | 0.00% | +100.0% |
| Q1 2021 | $1,060,000 | +102.7% | 17,163 | +37.1% | 0.00% | 0.0% |
| Q4 2020 | $523,000 | – | 12,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |